Mangalam Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on May 10, 2025.
MANORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Organics' board approved audited standalone and consolidated results for FY25 on May 10, 2025, with the auditor issuing an unmodified (clean) opinion. Standalone revenue from operations rose marginally to Rs. 40,984.75 lakhs (vs Rs. 40,543.35 lakhs in FY24), while total comprehensive income surged about 86% to Rs. 759.99 lakhs (from Rs. 407.57 lakhs), pushing EPS to Rs. 8.87 from Rs. 4.76. On a consolidated basis, revenue grew around 7% to Rs. 53,000.90 lakhs and total comprehensive income nearly tripled to Rs. 1,250.42 lakhs, lifting EPS to Rs. 14.60 from Rs. 4.92. However, operating cash flow swung sharply negative to Rs. -4,649.30 lakhs standalone (from +Rs. 5,472.15 lakhs), driven by an inventory build-up of over Rs. 8,300 lakhs. Total borrowings climbed to roughly Rs. 25,858 lakhs (from Rs. 16,288 lakhs), and cash on hand dropped to just Rs. 16.26 lakhs.
Strong profit growth and a clean audit are positives, but the steep working-capital stretch, surge in debt, and negative operating cash flow signal liquidity pressure that shareholders should monitor closely.